2019
DOI: 10.1111/jphp.13105
|View full text |Cite
|
Sign up to set email alerts
|

Single-dose diclofenac in healthy volunteers can cause decrease in renal perfusion measured by functional magnetic resonance imaging†

Abstract: Objectives We investigated changes of renal perfusion after topical and oral diclofenac administration in healthy volunteers using functional magnetic resonance imaging (MRI) with arterial spin labelling (ASL). Methods Twenty‐four healthy human participants (21–51 years) underwent 1.5T MRI before and 1 h after a single oral dose of diclofenac (50 mg). Twelve of 24 participants underwent an additional MRI examination following 3‐day topical diclofenac administration. For renal perfusion imaging, a flow‐sensitiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 47 publications
(110 reference statements)
0
5
0
Order By: Relevance
“…Moreover, after oral diclofenac intake, large interindividual differences in plasma concentrations have been observed [ 44 ]. These variations may account for therapeutic inefficiency due to low serum concentrations and the observed adverse reactions when higher serum levels were achieved.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, after oral diclofenac intake, large interindividual differences in plasma concentrations have been observed [ 44 ]. These variations may account for therapeutic inefficiency due to low serum concentrations and the observed adverse reactions when higher serum levels were achieved.…”
Section: Discussionmentioning
confidence: 99%
“…Issues such as repeatability and validation of ASL with alternative methods to measure renal perfusion were extensively addressed therewith and, therefore, will not be covered in the present manuscript. The previous literature review [8] as well as 12 studies published in the intervening period [11][12][13][14][15][16][17][18][19][20][21][22], the results of a series of surveys and the discussions that took place at the in-person meetings form the basis for the final recommendations presented here.…”
Section: Previous Literature Reviewmentioning
confidence: 99%
“…Non-steroidal anti-inflammatory drugs like diclofenac are also used to counteract COVID-19-induced fever and myalgia [38]. Furthermore, COVID-19 and cancer patients are at high-risk of acetaminophen-induced hepatotoxicity as reviewed in [39], diclofenac-induced gastrointestinal side effects as reviewed in [40], along with renal toxicity [41]; luckily, TQ administration protects against acetaminophen-induced hepatotoxicity [42]. In a recent study, TQ protected against diclofenac-induced kidney injury [42,43] and ameliorated GIT toxicity with proton pump inhibition activity [44,45].…”
Section: Benefits Of Thymoquinone As An Adjuvant In Covid-19mentioning
confidence: 99%